|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/15/22 Jrsis Health Care Corp. 10-Q 6/30/22 65:4M EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 617K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 20K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 20K
11: R1 Document And Entity Information HTML 70K
12: R2 Consolidated Balance Sheets HTML 143K
13: R3 Consolidated Balance Sheets (Parentheticals) HTML 28K
14: R4 Consolidated Statements of Operations and HTML 136K
Comprehensive Income (Unaudited)
15: R5 Consolidated Statement of Sharesholders? Equity HTML 84K
16: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 130K
17: R7 Description of Business and Organization HTML 28K
18: R8 Summaries of Significant Accounting Policies HTML 56K
19: R9 Discontinued Operations HTML 49K
20: R10 Property and Equipment HTML 27K
21: R11 Right-of-Use Assets and Lease Liabilities HTML 32K
22: R12 Derivative Financial Instruments HTML 24K
23: R13 Income Tax Expense HTML 35K
24: R14 Related Party Transactions HTML 29K
25: R15 Basic and Diluted Earnings Per Share HTML 32K
26: R16 Contingencies and Commitment HTML 24K
27: R17 Common Stock HTML 25K
28: R18 Subsequent Events HTML 23K
29: R19 Accounting Policies, by Policy (Policies) HTML 94K
30: R20 Summaries of Significant Accounting Policies HTML 39K
(Tables)
31: R21 Discontinued Operations (Tables) HTML 49K
32: R22 Property and Equipment (Tables) HTML 25K
33: R23 Right-of-Use Assets and Lease Liabilities (Tables) HTML 31K
34: R24 Income Tax Expense (Tables) HTML 32K
35: R25 Related Party Transactions (Tables) HTML 27K
36: R26 Basic and Diluted Earnings Per Share (Tables) HTML 31K
37: R27 Description of Business and Organization (Details) HTML 41K
38: R28 Summaries of Significant Accounting Policies HTML 49K
(Details)
39: R29 Summaries of Significant Accounting Policies HTML 36K
(Details) - Schedule of foreign currency
translation
40: R30 Summaries of Significant Accounting Policies HTML 26K
(Details) - Schedule of estimated useful lives for
property and equipment categories
41: R31 Summaries of Significant Accounting Policies HTML 29K
(Details) - Schedule of fair value hierarchy our
financial assets and liabilities
42: R32 Summaries of Significant Accounting Policies HTML 23K
(Details) - Schedule of changes in warrant
liability
43: R33 Discontinued Operations (Details) HTML 23K
44: R34 Discontinued Operations (Details) - Schedule of HTML 42K
discontinued operations in relation to Jiarun
hospital reported in the consolidated statements
of operations
45: R35 Discontinued Operations (Details) - Schedule of HTML 95K
major classes of assets and liabilities of
discontinued operations of Jiarun hospital
reported in the consolidated balance sheets
46: R36 Property and Equipment (Details) HTML 22K
47: R37 Property and Equipment (Details) - Schedule of HTML 31K
property and equipment
48: R38 Right-of-Use Assets and Lease Liabilities HTML 32K
(Details)
49: R39 Right-of-Use Assets and Lease Liabilities HTML 30K
(Details) - Schedule of unaudited condensed
consolidated balance sheet
50: R40 Right-of-Use Assets and Lease Liabilities HTML 28K
(Details) - Schedule of future annual minimum
lease payments for non-cancellable operating
leases
51: R41 Right-of-Use Assets and Lease Liabilities HTML 25K
(Details) - Schedule of right-of-use assets
52: R42 Derivative Financial Instruments (Details) HTML 22K
53: R43 Income Tax Expense (Details) HTML 27K
54: R44 Income Tax Expense (Details) - Schedule of HTML 44K
components of the allowance for US income tax
55: R45 Income Tax Expense (Details) - Schedule of income HTML 24K
tax reconciliation
56: R46 Related Party Transactions (Details) HTML 32K
57: R47 Related Party Transactions (Details) - Schedule of HTML 24K
amount due to related parties
58: R48 Related Party Transactions (Details) - Schedule of HTML 22K
operating expenses by related parties
59: R49 Basic and Diluted Earnings Per Share (Details) - HTML 82K
Schedule of basic net income per share
60: R50 Common Stock (Details) HTML 43K
63: XML IDEA XML File -- Filing Summary XML 119K
61: XML XBRL Instance -- f10q0622_jrsishealth_htm XML 720K
62: EXCEL IDEA Workbook of Financial Reports XLSX 102K
7: EX-101.CAL XBRL Calculations -- jrss-20220630_cal XML 106K
8: EX-101.DEF XBRL Definitions -- jrss-20220630_def XML 571K
9: EX-101.LAB XBRL Labels -- jrss-20220630_lab XML 1.09M
10: EX-101.PRE XBRL Presentations -- jrss-20220630_pre XML 567K
6: EX-101.SCH XBRL Schema -- jrss-20220630 XSD 166K
64: JSON XBRL Instance as JSON Data -- MetaLinks 305± 437K
65: ZIP XBRL Zipped Folder -- 0001213900-22-056091-xbrl Zip 182K
EXHIBIT 31.2
Certification of Principal Financial Officer
Section 302 Certification
| I, | Chen Zhuowen, certify that: |
| 1. | I have reviewed this quarterly report on Form 10-Q of JRSIS HEALTH CARE CORPORATION; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and the internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: | September 15, 2022 | /s/ Chen Zhuowen |
| Chen Zhuowen, Chief Financial Officer | ||
| (Principal Financial Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/15/22 | |||
| For Period end: | 6/30/22 | NT 10-Q | ||
| List all Filings | ||||